0001493152-24-007454.txt : 20240221 0001493152-24-007454.hdr.sgml : 20240221 20240221192943 ACCESSION NUMBER: 0001493152-24-007454 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240220 FILED AS OF DATE: 20240221 DATE AS OF CHANGE: 20240221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOLL ANDREW R. CENTRAL INDEX KEY: 0001542150 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35814 FILM NUMBER: 24661787 MAIL ADDRESS: STREET 1: 437 S HWY 101 STREET 2: STE 209 CITY: SOLANA BEACH STATE: CA ZIP: 92075 FORMER NAME: FORMER CONFORMED NAME: Boll Andrew DATE OF NAME CHANGE: 20120210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HARROW, INC. CENTRAL INDEX KEY: 0001360214 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 450567010 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 102 WOODMONT BLVD STREET 2: SUITE 610 CITY: NASHVILLE STATE: TN ZIP: 37215 BUSINESS PHONE: 615.733.4731 MAIL ADDRESS: STREET 1: 102 WOODMONT BLVD STREET 2: SUITE 610 CITY: NASHVILLE STATE: TN ZIP: 37215 FORMER COMPANY: FORMER CONFORMED NAME: HARROW HEALTH, INC. DATE OF NAME CHANGE: 20181228 FORMER COMPANY: FORMER CONFORMED NAME: Imprimis Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20120301 FORMER COMPANY: FORMER CONFORMED NAME: TRANSDEL PHARMACEUTICALS INC DATE OF NAME CHANGE: 20070912 4 1 ownership.xml X0508 4 2024-02-20 0 0001360214 HARROW, INC. HROW 0001542150 BOLL ANDREW R. C/O HARROW, INC. 102 WOODMONT BLVD, SUITE 610 NASHVILLE TN 37205 0 1 0 0 CHIEF FINANCIAL OFFICER 0 Common stock 2024-02-20 4 M 0 45000 10.67 A 586569 D Common stock 2024-02-20 4 M 0 18480 10.67 D 568089 D RSU 0.00 2024-02-20 4 M 0 45000 0 D Common Stock 45000 0 D The listed acquired 45,000 shares of Harrow, Inc. ("Harrow")_common stock represent restricted stock units (RSUs") granted to Mr. Boll on February 19, 2021 under the Issuer's 2017 Stock Incentive and Awards Plan, as amended. The RSUs vested after a three-year period following the award date. 18,480 shares of Harrow common stock listed as disposed were withheld from issuance by Harrow to satisfy Mr. Boll's payroll tax liability incident related to the vesting of the RSUs. Such withholding did not involve any market sales or other market transactions. /s/ Andrew R. Boll 2024-02-21